Photo from wikipedia
The optimal infliximab dose intensification strategy to address secondary loss of response (LOR) remains unclear. This study aimed to compare clinical and pharmacokinetic outcomes following (i) upfront infliximab re‐induction with… Click to show full abstract
The optimal infliximab dose intensification strategy to address secondary loss of response (LOR) remains unclear. This study aimed to compare clinical and pharmacokinetic outcomes following (i) upfront infliximab re‐induction with (ii) ongoing 6‐weekly dose interval shortening (DIS), after the same number of doses.
Keywords:
number doses;
intensification strategy;
response;
dose intensification
Journal Title: Journal of Gastroenterology and Hepatology
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Gastroenterology and Hepatology
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!